Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Improving cancer therapy by identification of novel drug leads modulating transcription termination bridging molecular biology and therapeutic applications

Project description

Targeting transcription termination in cancer

Cancer progression often involves dysregulation of gene expression, including defects in transcription termination. The latter constitutes the final step of RNA production that ensures correct expression of tumour suppressors and other key regulatory genes. Modulating this underexplored process offers a promising new therapeutic avenue. The ERC-funded proof-of-concept project ModulatEnds aims to identify novel anticancer drug candidates that modulate transcription termination. Researchers have developed an innovative methodology that directly measures changes in transcription termination and have successfully miniaturised and automated the process. The next phase will focus on the validation of a high-throughput screening platform to discover small molecule inhibitors of transcription termination. ModulatEnds is expected to pave the way for a new therapeutic strategy in oncology.

Objective

Our value proposition is improving cancer therapy by identification of novel anti-cancer candidate drug leads modulating transcription termination, bridging molecular cancer biology and therapeutic applications.

We have developed a methodology to directly measure alterations in transcription termination and successfully subjected it to miniaturization and automatization processes. We are applying for funding to validate a screening platform to identify small molecule inhibitors of transcription termination.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 150 000,00
Address
ULICA HENRYKA WIENIAWSKIEGO 1
61 712 POZNAN
Poland

See on map

Region
Makroregion północno-zachodni Wielkopolskie Miasto Poznań
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (1)

My booklet 0 0